Dr. Gu received his B.S. degree in Chemistry and M.S. degree in Polymer Chemistry and Physics from Nanjing University. In 2010, he obtained Ph.D. from the Department of Chemical and Biomolecular Engineering at the University of California, Los Angeles (UCLA). He was a Postdoctoral Associate working with Dr. Robert Langer at MIT and Harvard Medical School. Before he moved to Zhejiang University, he was a Full Professor in the Department of Bioengineering at UCLA. From 2012 to 2018, he was working in the Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University, where he was appointed as a Jackson Family Distinguished Professor. Dr. Gu’s group studies controlled drug delivery, biomaterials and cell therapy. He has published over 200 research papers and applied over 100 patents. Highlights of his innovations include glucose-responsive smart insulin patch and platelet-mediated cancer immunotherapy. He is the recipient of the Felix Franks Medal of the Royal Society of Chemistry (2019), Biomaterials Science Lectureship Award (2018), Young Investigator Award of CRS (2017), Sloan Research Fellowship (2016) and Pathway Award of the American Diabetes Association (ADA, 2015). MIT Technology Review listed him in 2015 as one of the top innovators under the age of 35 (TR35). He was elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE) in 2019. Dr. Gu serves as an Associate Editor for Science Advances and Nano Research.

Profile: https://person.zju.edu.cn/0020202